Publish results open access?
Details about the research group
The BSAC Drug Stability Testing Programme exists to provide evidence on the stability of agents and devices used in infection management practice, particularly those used in outpatient parenteral antimicrobial (OPAT) therapy services.
The programme will provide an expanding repository of open access data on drug and device stability compliant with UK NHS standards as provided by the yellow Covered Document. For the first time healthcare professionals will be able to reference open access stability data reports to aid decision making, inform practice and offer opportunities to improve patient safety and patient outcomes, especially within the OPAT arena. The programme objectives are central to the charitable objective of the British Society for Antimicrobial Chemotherapy which is “To support the acquisition and dissemination of knowledge in the field of antimicrobial chemotherapy”